PLA2G7 Antibody

Aliases: Platelet-activating factor acetylhydrolase precursor; 1 alkyl 2 acetylglycerophosphocholine esterase; 1-alkyl-2-acetylglycerophosphocholine esterase; 2 acetyl 1 alkylglycerophosphocholine esterase; 2-acetyl-1-alkylglycerophosphocholine esterase; EC 3.1.1.47 PAF acetylhydrolase PAF 2-acylhydrolase LDL associated phospholipase A2; Group VIIA phospholipase A2; Group-VIIA phospholipase A2; gVIIA PLA2; gVIIA-PLA2; LDL associated phospholipase A2; LDL PLA(2); LDL PLA2; LDL-associated phospholipase A2; LDL-PLA(2); Lipoprotein associated phospholipase A2; LP PLA2; PAF 2 acylhydrolase; PAF 2 acylhydrolase LDL associated phospholipase A2; PAF 2-acylhydrolase; PAF acetylhydrolase; PAFA_HUMAN; PAFAD; PAFAH; Phospholipase A2, group VII (platelet activating factor acetylhydrolase, plasma); PLA2G7; Platelet activating factor acetylhydrolase 2; Platelet activating factor acetylhydrolase; Platelet-activating factor acetylhydrolase
Antibody Type: Polyclonal Antibody
Antigen Species: Human
Uniprot ID: Q13093
Antigen: Recombinant Human Platelet-activating factor acetylhydrolase protein (49-441AA)
Host Species: Rabbit
Species Reactivity: Human
Tested Applications: ELISA, WB, IHC; Recommended dilution: WB:1:1000-1:5000, IHC:1:20-1:200
Clonality: Polyclonal
Isotype: IgG
Purification Method: Protein G purification
Conjugate: Non-conjugated
Buffer: 0.03% Proclin 300, 50% glycerol, 0.01M PBS, pH 7.4.
Form: Liquid
Stroage: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Target Name: PLA2G7
Research Area: Immunology